March 5, 2013
We are truly excited to launch our “Fifth Annual Father’s Day Rally Against Prostate Cancer” with a goal to reach one million persons in partnership with churches nationwide. PHEN clearly recognizes the challenge that lies ahead in accomplishing this goal. However, we believe that the successes of our Father Day Rallies since 2009 provide the foundation and impetus for meeting our objectives this year.
To realize our mission we are appealing to all churches to partner in this year’s Father’s Day effort as a unique opportunity to educate and support the health needs of your members and community. We are calling upon prostate cancer survivors and their family members to take on leadership roles within their churches in support of the Rally. This movement rests on our shoulders and we need your help.
I know there are a number of organizations and leaders within communities around the country who are performing outstanding work in the fight against prostate cancer. We invite you to join with us as a partner in this year’s Rally. Working together we have the opportunity to take a major step forward in accomplishing all our goals.
PHEN initiatives are made possible through the generous financial support of its industry partners, organizations and individuals. We will need your strong and continuing support for the success of the 2013
PHEN President, Thomas A. Farrington
Father’s Day Rally with its expanded size and scope.
Through our collective efforts we envision a grand celebration of historical significance on Father’ Day. The impact of educating, mobilizing and fully engaging Black America in the fight against prostate cancer will be profound for us all. Lives will be saved, suffering reduced and the overall effort to find a cure for this disease will be advanced.
I sincerely thank you for your support.
Thomas A. Farrington
February 6, 2013
This year PHEN is celebrating its Ten Year Anniversary! We have been on an exciting and productive journey during our first decade while paving a road for the future.
Over Ten Years of outstanding work in the Fight Against Prostate Cancer
I was diagnosed with prostate cancer in 2000 and founded PHEN in 2003 to increase awareness and knowledge about prostate cancer within Black America which suffers an alarming 140% higher death rate than for all other men. There is a widespread void of knowledge and actions needed to address this deadly crisis.
PHEN’S first ten years has been dedicated to mobilizing a series of national initiatives aimed at filling this void. These initiatives are achieving impressive results and PHEN is now widely recognized as a leader in prostate cancer patient education and advocacy efforts. We celebrate PHEN’s accomplishments with a great sense of progress and excitement, and with a strong foundation of enduring and proven initiatives on which to enhance and expand our efforts for the work that still lies ahead.
PHEN Milestones and Initiatives (Click to Read)
My sincerest appreciations to the many that supported PHEN, making our first decade possible and successful. Throughout 2013 PHEN will celebrate its ten year anniversary with ACTIONS as we continue executing our initiatives, collectively known as the “Rally Against Prostate Cancer.”
I invite you to celebrate with us by joining our rally and continuing your support of PHEN to help shape a future for all men absent prostate cancer.
Thomas A. Farrington
November 8, 2012
Today prostate cancer patients with advanced disease have three relative new treatments available that improve overall survival. Provenge, Zytiga and Xtandi have all been approved by the Food and Drug Administration (FDA) over the past two years. These treatments represent significant progress for patients who for years had only chemotherapy to rely upon following hormone therapy. But the good news does not stop here.
There are an increasing number of clinical trials using these “FDA approved” treatments. Importantly, these clinical trials are not experimental and seeking to prove the effectiveness and safety for these treatments. Effectiveness and safety were determined for each as part of the FDA approval process. Instead many of these trials are studies to better understand the treatments’ level of effectiveness relative to parameters such as stages of disease, genetic factors, in combination with other treatments, etc.
In most instances men participating in these trials are able to receive treatment with these expensive drugs for no cost and no increased risk. Clinical trials using these new treatments represent a new day for prostate cancer patients, especially for those that cannot afford these treatments.
It is important for African American men, who are at a higher risk for needing treatment for advanced disease, to participate in these trials to help better understand how these treatments can impact on eliminating the prostate cancer epidemic that we now suffer. Also, in some cases these trials will remove the access barrier that some men face.
PHEN will continue to highlight and focus on important clinical trials to insure that the men most impacted by prostate cancer are knowledgeable and have the opportunity to participate in this exciting new day for patients.
Remember, knowledge is the best defense against prostate cancer.
February 20, 2012
Thomas A. Farrington, PHEN President and Founder, discusses the Impact of Prostate Cancer and PHEN’s efforts to increase knowledge about the disease, with Dr. Luke Nordquist, Urology Cancer Center, Omaha, NE, on the Radio Show “Cancer Opinions with Dr. Luke.”
Prostate Cancer and the Impact on African American Men with Thomas A. Farrington
Dr. Luke Nordquist and Thomas A. Farrington - Click to Listen to Interview